Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.
- DOI
- 10.1111/dom.71223
- Published
- 2026-08-18
- Container
- Diabetes Obes Metab
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.71223,
title = {Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.},
author = {Ishibashi R and Koshizaka M and Hirayama K and Sakai T and Tatsumi T and Takatsuna Y and Baba T and Maezawa Y and Yokote K.},
year = {2026},
journal = {Diabetes Obes Metab},
doi = {10.1111/dom.71223},
url = {https://doi.org/10.1111/dom.71223}
}RIS
TY - JOUR TI - Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial. AU - Ishibashi R AU - Koshizaka M AU - Hirayama K AU - Sakai T AU - Tatsumi T AU - Takatsuna Y AU - Baba T AU - Maezawa Y AU - Yokote K. PY - 2026 JO - Diabetes Obes Metab DO - 10.1111/dom.71223 UR - https://doi.org/10.1111/dom.71223 ER -
APA
R, I., M, K., K, H., T, S., T, T., Y, T., T, B., Y, M., & K., Y. (2026). Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.. Diabetes Obes Metab. https://doi.org/10.1111/dom.71223
Source records
- europe-pmc · retrieved 2026-09-26T12:42:49.767Z